Development and Validation of a Predictive Nomogram for Myelosuppression Risk in Chronic Hepatitis B Patients Treated with Peginterferon
Lower BMI, WBC counts, GLB, and higher SCR levels are independent risk factors for myelosuppression among Peg-IFN-treated CHB patients. The predictive nomogram, based on those factors, is able to identify high-risk individuals for myelosuppression, thereby aiding in early alleviation of this side-effect.
Authors
- Zhilong Wen
- Pei Shi (ORCID: https://orcid.org/0009-0005-8677-9012)
- Jiwei Fu (ORCID: https://orcid.org/0009-0004-8839-4813)
- Wentao Zhu (ORCID: https://orcid.org/0000-0001-6371-7998)
- Mengyu Tao (ORCID: https://orcid.org/0000-0002-1500-304X)
- Ting Deng (ORCID: https://orcid.org/0000-0001-5477-7972)
- Xiaoping Wu (ORCID: https://orcid.org/0000-0003-2747-3185)
- Ting Zheng (ORCID: https://orcid.org/0009-0005-9938-0289)
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiangxi Provincial People's Hospital (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/idr.s508538
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00